New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 — Albany, New York

New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 is a clinical research site located in Albany, New York, United States 12206.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1?

New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 conducted?

New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 accredited by Crixeo Health?

New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology, P.C. 400 Patroon Creek Blvd, Suite 1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.